Zusammenfassung
Die präklinische Diagnose eines Schocks stützt sich noch immer auf Anamese und körperliche Untersuchung, Verletzungsmuster und einige wenige hämodynamische Parameter, die dem Notarzt zur Verfügung stehen. Neuere Studien belegen, dass ein differenziertes therapeutisches Vorgehen angezeigt ist. Bezüglich des traumatischen hypovolämisch-hämorrhagischen Schocks ist entscheidend, ob ein penetrierendes Trauma und/oder eine unstillbare Blutung vorliegt. In diesem Fall muss der Patient schnellstmöglich einer definitiven chirurgischen Versorgung zugeführt („scoop and run“) und eine moderate Hypotension („treat and run“) toleriert werden. Flüssigkeitssubstitution und Katecholamingabe müssen in diesem Falle zurückhaltend eingesetzt werden. Bei anderen Schockformen kann sehr viel aggressiver therapiert werden, um eine möglichst schnelle Verbesserung der mikrovaskulären Perfusion zu erreichen. Neben adäquater Flüssigkeitssubstitution in einer Kombination aus kolloiden und kristalloiden Lösungen sollten Katecholamine und ggf. Vasopressin eingesetzt werden.
Zentrale Bedeutung kommt bei der präklinischen Versorgung der Auswahl einer geeigneten Zielklinik zu, damit eine schnellstmögliche definitive und damit kausale Therapie erfolgen kann.
Abstract
The preclinical diagnosis of shock is still based on the patient’s history, the physical examination, the injury pattern and a few hemodynamic parameters available in the emergency set-up. The clinical picture is characterised by hypotension and tachycardia, tachypnoe and dyspnoea as well as cerebral impairment. Results from recent clinical trials indicate, that a adapted and specific therapeutic approach for the various shock forms is necessary. In case of traumatic hypovolemic-hemorrhagic shock it is of particular relevance if penetrating trauma and/or uncontrolled bleeding exists. Under these conditions an immediate definite surgical treatment is required (“scoop and run”) and a moderate hypotension should be tolerated. (“treat and run”). Fluid substitution and therapy with catecholamines should be used conservatively. In all other forms of shock the treatment approach can and should be more aggressive in order to improve microvascular perfusion as early as possible. Besides adequate fluid resuscitation in a combination of crystalloid and colloid solutions catecholamines and—under specific circumstances—also vasopressin should be used.
Of utmost importance in the pre-clinical management of patients in shock is the optimal selection of the centre that the patient is referred to in order to establish the fastest and best possible definite treatment for the patient.
Literatur
Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I, Schierhout G (2002) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev CD001208
Alderson P, Schierhout G, Roberts I, Bunn F (2003) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev CD001319
Bardenheuer, M, Obertacke, U, Waydhas, C, Nast-Kolb, D (2000) [Epidemiology of the severely injured patient. A prospective assessment of preclinical and clinical management. AG Polytrauma of DGU]. Unfallchirurg 103: 355–363
Baskett PJ (1990) ABC of major trauma. Management of hypovolaemic shock. BMJ 300: 1453–1457
Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care (2000) Hypotension. J Neurotrauma 17: 591–595
Calkins MD, Fitzgerald G, Bentley TB, Burris D (2000) Intraosseous infusion devices: a comparison for potential use in special operations. J Trauma 48: 1068–1074
Chesnut RM (1997) Avoidance of hypotension: conditio sine qua non of successful severe head-injury management. J Trauma 42: S4–S9
Chesnut RM, Marshall LF, Klauber MR et al. (1993) The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34: 216–222
Choi PT, Yip G, Quinonez LG, Cook DJ (1999) Crystalloids vs. colloids in fluid resuscitation: a systemic review. Crit Care Med 27: 200–210
Dark PM, Delooz HH, Hillier V, Hanson J, Little RA (2000) Monitoring the circulatory responses of shocked patients during fluid resuscitation in the emergency department. Intensive Care Med 26: 173–179
Dunser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107: 2313–2319
Dutton RP, Mackenzie CF, Scalea TM (2002) Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 52: 1141–1146
Forrest P (2001) Vasopressin and shock. Anaesth Intensive Care 29: 463–472
Fowler R, Pepe PE (2002) Prehospital care of the patient with major trauma. Emerg Med Clin North Am 20: 953–974
Gillham MJ, Parr MJA (2002) Resuscitation for major trauma. Curr Opin Anaesthesiol 15: 167–172
Hamilton-Davies C, Mythen MG, Salmon JB, Jacobson D, Shukla A, Webb AR (1997) Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med 23: 276–281
Kincaid EH, Meredith JW, Chang MC (2001) Determining optimal cardiac preload during resuscitation using measurements of ventricular compliance. J Trauma 50: 665–669
Kreimeier U, Christ F, Frey L et al. (1997) [Small-volume resuscitation for hypovolemic shock. Concept, experimental and clinical results]. Anaesthesist 46: 309–328
Kreimeier U, Lackner CK, Pruckner S, Ruppert M, Peter K (2002) [Permissive hypotension in severe trauma]. Anaesthesist 51: 787–799
Kreimeier U, Messmer K (2002) Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand 46: 625–638
Kwan, I, Bunn, F, Roberts I, WHO Pre-Hospital Trauma Care Steering Committee (2001) Timing and volume of fluid administration for patients with bleeding following trauma. Cochrane Database Syst Rev CD002245
Marzi I (1996) [Hemorrhagic shock]. Anaesthesist 45: 976–992
Michard F, Teboul JL (2000) Using heart-lung interactions to assess fluid responsiveness during mechanical ventilation. Crit Care 4: 282–289
Morales D, Madigan J, Cullinane S et al. (20–7-1999) Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100: 226–229
Muller-Werdan U, Werdan K (2000) [Anaphylaxis and allergy. Recommendations for emergency treatment]. Internist (Berl) 41: 363–373
Mullner M, Urbanek B, Havel C, Losert H, Gamper G (2004) Cochrane Database Syst Rev (in press)
Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349: 1498–1504
Nast-Kolb D, Trupka A, Ruchholtz S, Schweiberer L (1998) [Abdominal trauma]. Unfallchirurg 101: 82–91
Nolan JP, De Latorre FJ, Steen PA, Chamberlain DA, Bossaert LL (2002) Advanced life support drugs: do they really work? Curr Opin Crit Care 8: 212–218
Orlinsky M, Shoemaker W, Reis ED, Kerstein MD (2001) Current controversies in shock and resuscitation. Surg Clin North Am 81: 1217–1262
Prough DS, Lang J (1997) Therapy of patients with head injuries: key parameters for management. J Trauma 42: S10–S18
Roden DM (1994) Risks and benefits of antiarrhythmic therapy. N Engl J Med 331: 785–791
Spahn DR, Kocian R (2003) The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation. Can J Anaesth 50: S41–S47
Steg PG, Bonnefoy E, Chabaud S et al. (2003) Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 108: 2851–2856
Sutcliffe AJ (1996) Fluid resuscitation. Curr Opin Anaesthesiol 9: 178–182
Topol EJ (2003) Current status and future prospects for acute myocardial infarction therapy. Circulation 108: III6–13
Trunkey DD (1983) Trauma. Accidental and intentional injuries account for more years of life lost in the U.S. than cancer and heart disease. Among the prescribed remedies are improved preventive efforts, speedier surgery and further research. Sci Am 249: 28–35
Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29: 487–493
Voelckel WG, Wenzel V (2003) Managing hemorrhagic shock: fluids on the way out—drugs on the way in? Crit Care Med 31: 2552–2553
Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN (1997) Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 122: 609–616
Werdan K (2001) Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. Ther Apher 5: 115–122
Xavier LC, Kern KB (2003) Cardiopulmonary Resuscitation Guidelines 2000 update: what’s happened since? Curr Opin Crit Care 9: 218–221
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Christ, F., Lackner, C.K. Präklinische Versorgung des Patienten mit Schock. Internist 45, 267–276 (2004). https://doi.org/10.1007/s00108-004-1149-z
Issue Date:
DOI: https://doi.org/10.1007/s00108-004-1149-z